COR Q1 2024 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q1 2024 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$72.3B+15.0% YoY

Gross Profit

$2.1B3.0% margin

Operating Income

$751M1.0% margin

Net Income

$602M0.8% margin

EPS (Diluted)

$2.98

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

$885M

Free Cash Flow

$811M

Stock-Based Comp.

$63M

Balance Sheet

Total Assets

$64.7B

Total Liabilities

$63.6B

Stockholders' Equity

$912M

Cash & Equivalents

$3.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$72.3B	$62.8B	+15.0%
Gross Profit	$2.1B	$1.9B	+11.7%
Operating Income	$751M	$633M	+18.6%
Net Income	$602M	$480M	+25.4%

Revenue Segments

Pharmaceutical Distribution

$63.9B88%

International Healthcare Solutions

$7.1B10%

Animal Health

$1.3B2%

Geographic Segments

U.S. Healthcare Solutions

$65.2B90%

International Healthcare Solutions

$7.1B10%